Celcuity (CELC) Non Operating Income (2016 - 2025)
Celcuity (CELC) posted Non Operating Income of -$1.8 million for Q4 2025, down 85.55% on a QoQ basis from -$955000.0 in Q3 2025, and down 694.62% year-over-year from $298006.0 in Q4 2024.
Celcuity (CELC) Non Operating Income (2016 - 2025) Analysis & Trends
Celcuity's Non Operating Income history runs 9 years deep, the most recent figure standing at -$1.8 million for Q4 2025.
- Quarterly Non Operating Income fell 694.62% year-over-year to -$1.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.8 million (down 425.94% YoY) and the FY2025 annual result came in at -$4.8 million, down 425.94% from the prior year.
- Non Operating Income was -$1.8 million for Q4 2025 at Celcuity, down from -$955000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $881000.0 in Q1 2024 and bottomed at -$1.8 million in Q4 2025.
- A 4-year average of -$368362.2 and a median of -$359799.0 in 2022 frame the typical range for Non Operating Income.
- Annual changes were most pronounced in 2021 — Non Operating Income plunged 7499.34% — and 2022, when it jumped 41.48%.
- Celcuity's Non Operating Income stood at -$427460.0 in 2021, then jumped by 41.48% to -$250166.0 in 2022, then increased by 10.86% to -$223000.0 in 2024, then tumbled by 694.62% to -$1.8 million in 2025.
- Business Quant data shows CELC's Non Operating Income at -$1.8 million in Q4 2025, -$955000.0 in Q3 2025, and -$1.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -9.22 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 444,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 188.30 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 5.75 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -8.59 Mn |
| 10 | Celcuity | 3.89 Bn | 3.89 Bn | - | -1.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.77 Mn |
| Sep 30, 2025 | -955,000.00 |
| Jun 30, 2025 | -1.26 Mn |
| Mar 31, 2025 | -864,000.00 |
| Dec 31, 2024 | -223,000.00 |
| Sep 30, 2024 | 268,000.00 |
| Jun 30, 2024 | 562,000.00 |
| Mar 31, 2024 | 881,000.00 |
| Sep 30, 2022 | -250,166.00 |
| Jun 30, 2022 | -359,799.00 |
| Sep 30, 2021 | -427,460.00 |
| Jun 30, 2021 | -389,384.00 |
| Mar 31, 2021 | 101.00 |
| Dec 31, 2020 | 443.00 |
| Sep 30, 2020 | 5,777.00 |
| Jun 30, 2020 | 11,952.00 |
| Mar 31, 2020 | 63,818.00 |
| Dec 31, 2019 | 88,739.00 |
| Sep 30, 2019 | 107,061.00 |
| Jun 30, 2019 | 121,542.00 |